APO Research
Talk to an analyst

APO RESEARCH · REPORT

Neurovascular Interventional Devices

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Neurovascular Interventional Devices Industry Growth and Trends Forecast to 2032

4 July 2026103 pages

Choose your research edition.

Industry ResearchNeurovascular Interventional Devices Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Neurovascular Interventional Devices Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Neurovascular Interventional Devices Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Neurovascular Interventional Devices Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Neurovascular Interventional Devices Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Neurovascular Interventional Devices market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Neurovascular Interventional Devices is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Neurovascular Interventional Devices is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Neurovascular Interventional Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Neurovascular Interventional Devices include Johnson & Johnson, Medtronic PLC, W.L. Gore & Associates, Terumo Corporation, Stryker Corporation, Penumbra, Inc., Microport Scientific Corporation, Merit Medical Systems, Inc. and Cardinal Health, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Neurovascular Interventional Devices market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Neurovascular Interventional Devices market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Neurovascular Interventional Devices market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Neurovascular Interventional Devices.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Neurovascular Interventional Devices market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Neurovascular Interventional Devices Market by Company

Johnson & Johnson

Medtronic PLC

W.L. Gore & Associates

Terumo Corporation

Stryker Corporation

Penumbra, Inc.

Microport Scientific Corporation

Merit Medical Systems, Inc.

Cardinal Health

Boston Scientific Corporation

Abbott Laboratories

Neurovascular Interventional Devices Segment by Type

Embolization Coils

Intrasaccular Devices

Intracranial Stents

Carotid Stents

Flow Diverters

Others

Neurovascular Interventional Devices Segment by Application

Ambulatory Surgical Centers

Hospitals

Clinics

Others

Neurovascular Interventional Devices Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Neurovascular Interventional Devices market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Neurovascular Interventional Devices and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Neurovascular Interventional Devices.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Neurovascular Interventional Devices manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Neurovascular Interventional Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Embolization Coils Table 2. Major Company of Intrasaccular Devices Table 3. Major Company of Intracranial Stents Table 4. Major Company of Carotid Stents Table 5. Major Company of Flow Diverters Table 6. Major Company of Others Table 7. Global Neurovascular Interventional Devices Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 8. Global Neurovascular Interventional Devices Sales by Type (2021-2026) & (k units) Table 9. Global Neurovascular Interventional Devices Sales Market Share in Volume by Type (2021-2026) Table 10. Global Neurovascular Interventional Devices Sales by Type (2021-2026) & (US$ Million) Table 11. Global Neurovascular Interventional Devices Sales Market Share in Value by Type (2021-2026) Table 12. Global Neurovascular Interventional Devices Price by Type (2021-2026) & (USD/unit) Table 13. Global Neurovascular Interventional Devices Sales by Type (2027-2032) & (k units) Table 14. Global Neurovascular Interventional Devices Sales Market Share in Volume by Type (2027-2032) Table 15. Global Neurovascular Interventional Devices Sales by Type (2027-2032) & (US$ Million) Table 16. Global Neurovascular Interventional Devices Sales Market Share in Value by Type (2027-2032) Table 17. Global Neurovascular Interventional Devices Price by Type (2027-2032) & (USD/unit) Table 18. North America Neurovascular Interventional Devices Sales by Type (2021-2026) & (k units) Table 19. North America Neurovascular Interventional Devices Sales by Type (2021-2026) & (US$ Million) Table 20. Europe Neurovascular Interventional Devices Sales by Type (2021-2026) & (k units) Table 21. Europe Neurovascular Interventional Devices Sales by Type (2021-2026) & (US$ Million) Table 22. Asia-Pacific Neurovascular Interventional Devices Sales by Type (2021-2026) & (k units) Table 23. Asia-Pacific Neurovascular Interventional Devices Sales by Type (2021-2026) & (US$ Million) Table 24. Latin America Neurovascular Interventional Devices Sales by Type (2021-2026) & (k units) Table 25. Latin America Neurovascular Interventional Devices Sales by Type (2021-2026) & (US$ Million) Table 26. Middle East and Africa Neurovascular Interventional Devices Sales by Type (2021-2026) & (k units) Table 27. Middle East and Africa Neurovascular Interventional Devices Sales by Type (2021-2026) & (US$ Million) Table 28. Neurovascular Interventional Devices Industry Trends Table 29. Neurovascular Interventional Devices Industry Drivers Table 30. Neurovascular Interventional Devices Industry Opportunities and Challenges Table 31. Neurovascular Interventional Devices Industry Restraints Table 32. Global Neurovascular Interventional Devices Sales Revenue by Company (US$ Million) & (2021-2026) Table 33. Global Neurovascular Interventional Devices Revenue Market Share by Company (2021-2026) Table 34. Global Neurovascular Interventional Devices Sales by Company (2021-2026) & (k units) Table 35. Global Neurovascular Interventional Devices Sales Share by Company (2021-2026) Table 36. Global Neurovascular Interventional Devices Market Price by Company (2021-2026) & (USD/unit) Table 37. Global Neurovascular Interventional Devices Industry Company Ranking, 2024 VS 2025 VS 2026 Table 38. Global Neurovascular Interventional Devices Major Company Production Sites and Headquarters Table 39. Global Neurovascular Interventional Devices Company, Product Type & Application Table 40. Global Neurovascular Interventional Devices Company Establishment Date Table 41. Global Company Market Concentration Ratio (CR5 and HHI) Table 42. Global Neurovascular Interventional Devices by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 43. Global Neurovascular Interventional Devices Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 44. Global Neurovascular Interventional Devices Sales by Region (2021-2026) & (k units) Table 45. Global Neurovascular Interventional Devices Sales Market Share in Volume by Region (2021-2026) Table 46. Global Neurovascular Interventional Devices Sales by Region (2021-2026) & (US$ Million) Table 47. Global Neurovascular Interventional Devices Sales Market Share in Value by Region (2021-2026) Table 48. Global Neurovascular Interventional Devices Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 49. Global Neurovascular Interventional Devices Sales by Region (2027-2032) & (k units) Table 50. Global Neurovascular Interventional Devices Sales Market Share in Volume by Region (2027-2032) Table 51. Global Neurovascular Interventional Devices Sales by Region (2027-2032) & (US$ Million) Table 52. Global Neurovascular Interventional Devices Sales Market Share in Value by Region (2027-2032) Table 53. Global Neurovascular Interventional Devices Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2027-2032) Table 54. Global Neurovascular Interventional Devices Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 55. Global Neurovascular Interventional Devices Sales by Application (2021-2026) & (k units) Table 56. Global Neurovascular Interventional Devices Sales Market Share in Volume by Application (2021-2026) Table 57. Global Neurovascular Interventional Devices Sales by Application (2021-2026) & (US$ Million) Table 58. Global Neurovascular Interventional Devices Sales Market Share in Value by Application (2021-2026) Table 59. Global Neurovascular Interventional Devices Price by Application (2021-2026) & (USD/unit) Table 60. Global Neurovascular Interventional Devices Sales by Application (2027-2032) & (k units) Table 61. Global Neurovascular Interventional Devices Sales Market Share in Volume by Application (2027-2032) Table 62. Global Neurovascular Interventional Devices Sales by Application (2027-2032) & (US$ Million) Table 63. Global Neurovascular Interventional Devices Sales Market Share in Value by Application (2027-2032) Table 64. Global Neurovascular Interventional Devices Price by Application (2027-2032) & (USD/unit) Table 65. North America Neurovascular Interventional Devices Sales by Application (2021-2026) & (k units) Table 66. North America Neurovascular Interventional Devices Sales by Application (2021-2026) & (US$ Million) Table 67. Europe Neurovascular Interventional Devices Sales by Application (2021-2026) & (k units) Table 68. Europe Neurovascular Interventional Devices Sales by Application (2021-2026) & (US$ Million) Table 69. Asia-Pacific Neurovascular Interventional Devices Sales by Application (2021-2026) & (k units) Table 70. Asia-Pacific Neurovascular Interventional Devices Sales by Application (2021-2026) & (US$ Million) Table 71. Latin America Neurovascular Interventional Devices Sales by Application (2021-2026) & (k units) Table 72. Latin America Neurovascular Interventional Devices Sales by Application (2021-2026) & (US$ Million) Table 73. Middle East and Africa Neurovascular Interventional Devices Sales by Application (2021-2026) & (k units) Table 74. Middle East and Africa Neurovascular Interventional Devices Sales by Application (2021-2026) & (US$ Million) Table 75. Johnson & Johnson Company Information Table 76. Johnson & Johnson Business Overview Table 77. Johnson & Johnson Neurovascular Interventional Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 78. Johnson & Johnson Neurovascular Interventional Devices Product Portfolio Table 79. Johnson & Johnson Recent Development Table 80. Medtronic PLC Company Information Table 81. Medtronic PLC Business Overview Table 82. Medtronic PLC Neurovascular Interventional Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 83. Medtronic PLC Neurovascular Interventional Devices Product Portfolio Table 84. Medtronic PLC Recent Development Table 85. W.L. Gore & Associates Company Information Table 86. W.L. Gore & Associates Business Overview Table 87. W.L. Gore & Associates Neurovascular Interventional Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 88. W.L. Gore & Associates Neurovascular Interventional Devices Product Portfolio Table 89. W.L. Gore & Associates Recent Development Table 90. Terumo Corporation Company Information Table 91. Terumo Corporation Business Overview Table 92. Terumo Corporation Neurovascular Interventional Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. Terumo Corporation Neurovascular Interventional Devices Product Portfolio Table 94. Terumo Corporation Recent Development Table 95. Stryker Corporation Company Information Table 96. Stryker Corporation Business Overview Table 97. Stryker Corporation Neurovascular Interventional Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. Stryker Corporation Neurovascular Interventional Devices Product Portfolio Table 99. Stryker Corporation Recent Development Table 100. Penumbra, Inc. Company Information Table 101. Penumbra, Inc. Business Overview Table 102. Penumbra, Inc. Neurovascular Interventional Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. Penumbra, Inc. Neurovascular Interventional Devices Product Portfolio Table 104. Penumbra, Inc. Recent Development Table 105. Microport Scientific Corporation Company Information Table 106. Microport Scientific Corporation Business Overview Table 107. Microport Scientific Corporation Neurovascular Interventional Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 108. Microport Scientific Corporation Neurovascular Interventional Devices Product Portfolio Table 109. Microport Scientific Corporation Recent Development Table 110. Merit Medical Systems, Inc. Company Information Table 111. Merit Medical Systems, Inc. Business Overview Table 112. Merit Medical Systems, Inc. Neurovascular Interventional Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 113. Merit Medical Systems, Inc. Neurovascular Interventional Devices Product Portfolio Table 114. Merit Medical Systems, Inc. Recent Development Table 115. Cardinal Health Company Information Table 116. Cardinal Health Business Overview Table 117. Cardinal Health Neurovascular Interventional Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 118. Cardinal Health Neurovascular Interventional Devices Product Portfolio Table 119. Cardinal Health Recent Development Table 120. Boston Scientific Corporation Company Information Table 121. Boston Scientific Corporation Business Overview Table 122. Boston Scientific Corporation Neurovascular Interventional Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 123. Boston Scientific Corporation Neurovascular Interventional Devices Product Portfolio Table 124. Boston Scientific Corporation Recent Development Table 125. Abbott Laboratories Company Information Table 126. Abbott Laboratories Business Overview Table 127. Abbott Laboratories Neurovascular Interventional Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 128. Abbott Laboratories Neurovascular Interventional Devices Product Portfolio Table 129. Abbott Laboratories Recent Development Table 130. North America Neurovascular Interventional Devices Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 131. North America Neurovascular Interventional Devices Sales by Country (2021-2026) & (k units) Table 132. North America Neurovascular Interventional Devices Sales Market Share by Country (2021-2026) Table 133. North America Neurovascular Interventional Devices Sales Forecast by Country (2027-2032) & (k units) Table 134. North America Neurovascular Interventional Devices Sales Market Share Forecast by Country (2027-2032) Table 135. North America Neurovascular Interventional Devices Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 136. North America Neurovascular Interventional Devices Market Size by Country (2021-2026) & (US$ Million) Table 137. North America Neurovascular Interventional Devices Market Share by Country (2021-2026) Table 138. North America Neurovascular Interventional Devices Market Size Forecast by Country (2027-2032) & (US$ Million) Table 139. North America Neurovascular Interventional Devices Market Share Forecast by Country (2027-2032) Table 140. Europe Neurovascular Interventional Devices Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 141. Europe Neurovascular Interventional Devices Sales by Country (2021-2026) & (k units) Table 142. Europe Neurovascular Interventional Devices Sales Market Share by Country (2021-2026) Table 143. Europe Neurovascular Interventional Devices Sales Forecast by Country (2027-2032) & (k units) Table 144. Europe Neurovascular Interventional Devices Sales Market Share Forecast by Country (2027-2032) Table 145. Europe Neurovascular Interventional Devices Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 146. Europe Neurovascular Interventional Devices Market Size by Country (2021-2026) & (US$ Million) Table 147. Europe Neurovascular Interventional Devices Market Share by Country (2021-2026) Table 148. Europe Neurovascular Interventional Devices Market Size Forecast by Country (2027-2032) & (US$ Million) Table 149. Europe Neurovascular Interventional Devices Market Share Forecast by Country (2027-2032) Table 150. Asia-Pacific Neurovascular Interventional Devices Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 151. Asia-Pacific Neurovascular Interventional Devices Sales by Country (2021-2026) & (k units) Table 152. Asia-Pacific Neurovascular Interventional Devices Sales Market Share by Country (2021-2026) Table 153. Asia-Pacific Neurovascular Interventional Devices Sales Forecast by Country (2027-2032) & (k units) Table 154. Asia-Pacific Neurovascular Interventional Devices Sales Market Share Forecast by Country (2027-2032) Table 155. Asia-Pacific Neurovascular Interventional Devices Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 156. Asia-Pacific Neurovascular Interventional Devices Market Size by Country (2021-2026) & (US$ Million) Table 157. Asia-Pacific Neurovascular Interventional Devices Market Share by Country (2021-2026) Table 158. Asia-Pacific Neurovascular Interventional Devices Market Size Forecast by Country (2027-2032) & (US$ Million) Table 159. Asia-Pacific Neurovascular Interventional Devices Market Share Forecast by Country (2027-2032) Table 160. Latin America Neurovascular Interventional Devices Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 161. Latin America Neurovascular Interventional Devices Sales by Country (2021-2026) & (k units) Table 162. Latin America Neurovascular Interventional Devices Sales Market Share by Country (2021-2026) Table 163. Latin America Neurovascular Interventional Devices Sales Forecast by Country (2027-2032) & (k units) Table 164. Latin America Neurovascular Interventional Devices Sales Market Share Forecast by Country (2027-2032) Table 165. Latin America Neurovascular Interventional Devices Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 166. Latin America Neurovascular Interventional Devices Market Size by Country (2021-2026) & (US$ Million) Table 167. Latin America Neurovascular Interventional Devices Market Share by Country (2021-2026) Table 168. Latin America Neurovascular Interventional Devices Market Size Forecast by Country (2027-2032) & (US$ Million) Table 169. Latin America Neurovascular Interventional Devices Market Share Forecast by Country (2027-2032) Table 170. Middle East and Africa Neurovascular Interventional Devices Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 171. Middle East and Africa Neurovascular Interventional Devices Sales by Country (2021-2026) & (k units) Table 172. Middle East and Africa Neurovascular Interventional Devices Sales Market Share by Country (2021-2026) Table 173. Middle East and Africa Neurovascular Interventional Devices Sales Forecast by Country (2027-2032) & (k units) Table 174. Middle East and Africa Neurovascular Interventional Devices Sales Market Share Forecast by Country (2027-2032) Table 175. Middle East and Africa Neurovascular Interventional Devices Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 176. Middle East and Africa Neurovascular Interventional Devices Market Size by Country (2021-2026) & (US$ Million) Table 177. Middle East and Africa Neurovascular Interventional Devices Market Share by Country (2021-2026) Table 178. Middle East and Africa Neurovascular Interventional Devices Market Size Forecast by Country (2027-2032) & (US$ Million) Table 179. Middle East and Africa Neurovascular Interventional Devices Market Share Forecast by Country (2027-2032) Table 180. Key Raw Materials Table 181. Raw Materials Key Suppliers Table 182. Neurovascular Interventional Devices Distributors List Table 183. Neurovascular Interventional Devices Customers List Table 184. Research Programs/Design for This Report Table 185. Authors List of This Report Table 186. Secondary Sources Table 187. Primary Sources List of Figures Figure 1. Neurovascular Interventional Devices Image Figure 2. Global Neurovascular Interventional Devices Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Neurovascular Interventional Devices Market Size (2021-2032) & (US$ Million) Figure 4. Global Neurovascular Interventional Devices Sales (2021-2032) & (k units) Figure 5. Embolization Coils Image Figure 6. Global Embolization Coils Sales YoY Growth (2021-2032) & (k units) Figure 7. Intrasaccular Devices Image Figure 8. Global Intrasaccular Devices Sales YoY Growth (2021-2032) & (k units) Figure 9. Intracranial Stents Image Figure 10. Global Intracranial Stents Sales YoY Growth (2021-2032) & (k units) Figure 11. Carotid Stents Image Figure 12. Global Carotid Stents Sales YoY Growth (2021-2032) & (k units) Figure 13. Flow Diverters Image Figure 14. Global Flow Diverters Sales YoY Growth (2021-2032) & (k units) Figure 15. Others Image Figure 16. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 17. Global Neurovascular Interventional Devices Market Size Overview by Type (2021-2032) & (US$ Million) Figure 18. Global Neurovascular Interventional Devices Market Share by Type 2025 VS 2032 Figure 19. North America Neurovascular Interventional Devices Sales Market Share in Volume by Type in 2025 Figure 20. North America Neurovascular Interventional Devices Sales Market Share in Value by Type in 2025 Figure 21. Europe Neurovascular Interventional Devices Sales Market Share in Volume by Type in 2025 Figure 22. Europe Neurovascular Interventional Devices Sales Market Share in Value by Type in 2025 Figure 23. Asia-Pacific Neurovascular Interventional Devices Sales Market Share in Volume by Type in 2025 Figure 24. Asia-Pacific Neurovascular Interventional Devices Sales Market Share in Value by Type in 2025 Figure 25. Latin America Neurovascular Interventional Devices Sales Market Share in Volume by Type in 2025 Figure 26. Latin America Neurovascular Interventional Devices Sales Market Share in Value by Type in 2025 Figure 27. Middle East and Africa Neurovascular Interventional Devices Sales Market Share in Volume by Type in 2025 Figure 28. Middle East and Africa Neurovascular Interventional Devices Sales Market Share in Value by Type in 2025 Figure 29. Global Top 5 and 10 Neurovascular Interventional Devices Players Market Share by Revenue in 2025 Figure 30. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 31. Ambulatory Surgical Centers Image Figure 32. Global Ambulatory Surgical Centers Sales YoY Growth (2021-2032) & (k units) Figure 33. Hospitals Image Figure 34. Global Hospitals Sales YoY Growth (2021-2032) & (k units) Figure 35. Clinics Image Figure 36. Global Clinics Sales YoY Growth (2021-2032) & (k units) Figure 37. Others Image Figure 38. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 39. Global Neurovascular Interventional Devices Market Size Overview by Application (2021-2032) & (US$ Million) Figure 40. Global Neurovascular Interventional Devices Market Share by Application 2025 VS 2032 Figure 41. North America Neurovascular Interventional Devices Sales Market Share in Volume by Application in 2025 Figure 42. North America Neurovascular Interventional Devices Sales Market Share in Value by Application in 2025 Figure 43. Europe Neurovascular Interventional Devices Sales Market Share in Volume by Application in 2025 Figure 44. Europe Neurovascular Interventional Devices Sales Market Share in Value by Application in 2025 Figure 45. Asia-Pacific Neurovascular Interventional Devices Sales Market Share in Volume by Application in 2025 Figure 46. Asia-Pacific Neurovascular Interventional Devices Sales Market Share in Value by Application in 2025 Figure 47. Latin America Neurovascular Interventional Devices Sales Market Share in Volume by Application in 2025 Figure 48. Latin America Neurovascular Interventional Devices Sales Market Share in Value by Application in 2025 Figure 49. Middle East and Africa Neurovascular Interventional Devices Sales Market Share in Volume by Application in 2025 Figure 50. Middle East and Africa Neurovascular Interventional Devices Sales Market Share in Value by Application in 2025 Figure 51. North America Neurovascular Interventional Devices Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. North America Neurovascular Interventional Devices Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. North America Neurovascular Interventional Devices Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. North America Neurovascular Interventional Devices Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Neurovascular Interventional Devices Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Europe Neurovascular Interventional Devices Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Europe Neurovascular Interventional Devices Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Europe Neurovascular Interventional Devices Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Neurovascular Interventional Devices Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 60. Asia-Pacific Neurovascular Interventional Devices Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Neurovascular Interventional Devices Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Asia-Pacific Neurovascular Interventional Devices Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Neurovascular Interventional Devices Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 64. Latin America Neurovascular Interventional Devices Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Latin America Neurovascular Interventional Devices Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Latin America Neurovascular Interventional Devices Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Neurovascular Interventional Devices Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 68. Middle East and Africa Neurovascular Interventional Devices Sales Share by Country: 2021 VS 2025 VS 2032 Figure 69. Middle East and Africa Neurovascular Interventional Devices Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 70. Middle East and Africa Neurovascular Interventional Devices Market Share by Country: 2021 VS 2025 VS 2032 Figure 71. Neurovascular Interventional Devices Value Chain Figure 72. Key Raw Materials Price Figure 73. Manufacturing Cost Structure Figure 74. Neurovascular Interventional Devices Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • Embolization Coils
  • Intrasaccular Devices
  • Intracranial Stents
  • Carotid Stents
  • Flow Diverters
  • Others
Applications
  • Ambulatory Surgical Centers
  • Hospitals
  • Clinics
  • Others
Companies covered
  • Johnson & Johnson
  • Medtronic PLC
  • W.L. Gore & Associates
  • Terumo Corporation
  • Stryker Corporation
  • Penumbra, Inc.
  • Microport Scientific Corporation
  • Merit Medical Systems, Inc.
  • Cardinal Health
  • Boston Scientific Corporation
  • Abbott Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Neurovascular Interventional Devices Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Neurovascular Interventional Devices Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Neurovascular Interventional Devices Market by Type
  6. 1.3.1 Embolization Coils
  7. 1.3.2 Intrasaccular Devices
  8. 1.3.3 Intracranial Stents
  9. 1.3.4 Carotid Stents
  10. 1.3.5 Flow Diverters
  11. 1.3.6 Others
  12. 1.4 Global Neurovascular Interventional Devices Market Size by Type
  13. 1.4.1 Global Neurovascular Interventional Devices Market Size Overview by Type (2021-2032)
  14. 1.4.2 Global Neurovascular Interventional Devices Historic Market Size Review by Type (2021-2026)
  15. 1.4.3 Global Neurovascular Interventional Devices Forecasted Market Size by Type (2027-2032)
  16. 1.5 Key Regions Market Size by Type
  17. 1.5.1 North America Neurovascular Interventional Devices Sales Breakdown by Type (2021-2026)
  18. 1.5.2 Europe Neurovascular Interventional Devices Sales Breakdown by Type (2021-2026)
  19. 1.5.3 Asia-Pacific Neurovascular Interventional Devices Sales Breakdown by Type (2021-2026)
  20. 1.5.4 South America Neurovascular Interventional Devices Sales Breakdown by Type (2021-2026)
  21. 1.5.5 Middle East and Africa Neurovascular Interventional Devices Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Neurovascular Interventional Devices Industry Trends
  2. 2.2 Neurovascular Interventional Devices Industry Drivers
  3. 2.3 Neurovascular Interventional Devices Industry Opportunities and Challenges
  4. 2.4 Neurovascular Interventional Devices Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Neurovascular Interventional Devices Revenue (2021-2026)
  2. 3.2 Global Top Players by Neurovascular Interventional Devices Sales (2021-2026)
  3. 3.3 Global Top Players by Neurovascular Interventional Devices Price (2021-2026)
  4. 3.4 Global Neurovascular Interventional Devices Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Neurovascular Interventional Devices Major Company Production Sites & Headquarters
  6. 3.6 Global Neurovascular Interventional Devices Company, Product Type & Application
  7. 3.7 Global Neurovascular Interventional Devices Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Neurovascular Interventional Devices Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Neurovascular Interventional Devices Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Neurovascular Interventional Devices Tier 1, Tier 2, and Tier 3
4 Neurovascular Interventional Devices Regional Status and Outlook
  1. 4.1 Global Neurovascular Interventional Devices Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Neurovascular Interventional Devices Historic Market Size by Region
  3. 4.2.1 Global Neurovascular Interventional Devices Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Neurovascular Interventional Devices Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Neurovascular Interventional Devices Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Neurovascular Interventional Devices Forecasted Market Size by Region
  7. 4.3.1 Global Neurovascular Interventional Devices Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Neurovascular Interventional Devices Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Neurovascular Interventional Devices Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Neurovascular Interventional Devices by Application
  1. 5.1 Neurovascular Interventional Devices Market by Application
  2. 5.1.1 Ambulatory Surgical Centers
  3. 5.1.2 Hospitals
  4. 5.1.3 Clinics
  5. 5.1.4 Others
  6. 5.2 Global Neurovascular Interventional Devices Market Size by Application
  7. 5.2.1 Global Neurovascular Interventional Devices Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Neurovascular Interventional Devices Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Neurovascular Interventional Devices Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Neurovascular Interventional Devices Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Neurovascular Interventional Devices Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Neurovascular Interventional Devices Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Neurovascular Interventional Devices Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Neurovascular Interventional Devices Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Johnson & Johnson
  2. 6.1.1 Johnson & Johnson Company Information
  3. 6.1.2 Johnson & Johnson Business Overview
  4. 6.1.3 Johnson & Johnson Neurovascular Interventional Devices Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Johnson & Johnson Neurovascular Interventional Devices Product Portfolio
  6. 6.1.5 Johnson & Johnson Recent Developments
  7. 6.2 Medtronic PLC
  8. 6.2.1 Medtronic PLC Company Information
  9. 6.2.2 Medtronic PLC Business Overview
  10. 6.2.3 Medtronic PLC Neurovascular Interventional Devices Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Medtronic PLC Neurovascular Interventional Devices Product Portfolio
  12. 6.2.5 Medtronic PLC Recent Developments
  13. 6.3 W.L. Gore & Associates
  14. 6.3.1 W.L. Gore & Associates Company Information
  15. 6.3.2 W.L. Gore & Associates Business Overview
  16. 6.3.3 W.L. Gore & Associates Neurovascular Interventional Devices Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 W.L. Gore & Associates Neurovascular Interventional Devices Product Portfolio
  18. 6.3.5 W.L. Gore & Associates Recent Developments
  19. 6.4 Terumo Corporation
  20. 6.4.1 Terumo Corporation Company Information
  21. 6.4.2 Terumo Corporation Business Overview
  22. 6.4.3 Terumo Corporation Neurovascular Interventional Devices Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Terumo Corporation Neurovascular Interventional Devices Product Portfolio
  24. 6.4.5 Terumo Corporation Recent Developments
  25. 6.5 Stryker Corporation
  26. 6.5.1 Stryker Corporation Company Information
  27. 6.5.2 Stryker Corporation Business Overview
  28. 6.5.3 Stryker Corporation Neurovascular Interventional Devices Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Stryker Corporation Neurovascular Interventional Devices Product Portfolio
  30. 6.5.5 Stryker Corporation Recent Developments
  31. 6.6 Penumbra, Inc.
  32. 6.6.1 Penumbra, Inc. Company Information
  33. 6.6.2 Penumbra, Inc. Business Overview
  34. 6.6.3 Penumbra, Inc. Neurovascular Interventional Devices Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Penumbra, Inc. Neurovascular Interventional Devices Product Portfolio
  36. 6.6.5 Penumbra, Inc. Recent Developments
  37. 6.7 Microport Scientific Corporation
  38. 6.7.1 Microport Scientific Corporation Company Information
  39. 6.7.2 Microport Scientific Corporation Business Overview
  40. 6.7.3 Microport Scientific Corporation Neurovascular Interventional Devices Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Microport Scientific Corporation Neurovascular Interventional Devices Product Portfolio
  42. 6.7.5 Microport Scientific Corporation Recent Developments
  43. 6.8 Merit Medical Systems, Inc.
  44. 6.8.1 Merit Medical Systems, Inc. Company Information
  45. 6.8.2 Merit Medical Systems, Inc. Business Overview
  46. 6.8.3 Merit Medical Systems, Inc. Neurovascular Interventional Devices Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Merit Medical Systems, Inc. Neurovascular Interventional Devices Product Portfolio
  48. 6.8.5 Merit Medical Systems, Inc. Recent Developments
  49. 6.9 Cardinal Health
  50. 6.9.1 Cardinal Health Company Information
  51. 6.9.2 Cardinal Health Business Overview
  52. 6.9.3 Cardinal Health Neurovascular Interventional Devices Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Cardinal Health Neurovascular Interventional Devices Product Portfolio
  54. 6.9.5 Cardinal Health Recent Developments
  55. 6.10 Boston Scientific Corporation
  56. 6.10.1 Boston Scientific Corporation Company Information
  57. 6.10.2 Boston Scientific Corporation Business Overview
  58. 6.10.3 Boston Scientific Corporation Neurovascular Interventional Devices Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Boston Scientific Corporation Neurovascular Interventional Devices Product Portfolio
  60. 6.10.5 Boston Scientific Corporation Recent Developments
  61. 6.11 Abbott Laboratories
  62. 6.11.1 Abbott Laboratories Company Information
  63. 6.11.2 Abbott Laboratories Business Overview
  64. 6.11.3 Abbott Laboratories Neurovascular Interventional Devices Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Abbott Laboratories Neurovascular Interventional Devices Product Portfolio
  66. 6.11.5 Abbott Laboratories Recent Developments
7 North America by Country
  1. 7.1 North America Neurovascular Interventional Devices Sales by Country
  2. 7.1.1 North America Neurovascular Interventional Devices Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Neurovascular Interventional Devices Sales by Country (2021-2026)
  4. 7.1.3 North America Neurovascular Interventional Devices Sales Forecast by Country (2027-2032)
  5. 7.2 North America Neurovascular Interventional Devices Market Size by Country
  6. 7.2.1 North America Neurovascular Interventional Devices Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Neurovascular Interventional Devices Market Size by Country (2021-2026)
  8. 7.2.3 North America Neurovascular Interventional Devices Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Neurovascular Interventional Devices Sales by Country
  2. 8.1.1 Europe Neurovascular Interventional Devices Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Neurovascular Interventional Devices Sales by Country (2021-2026)
  4. 8.1.3 Europe Neurovascular Interventional Devices Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Neurovascular Interventional Devices Market Size by Country
  6. 8.2.1 Europe Neurovascular Interventional Devices Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Neurovascular Interventional Devices Market Size by Country (2021-2026)
  8. 8.2.3 Europe Neurovascular Interventional Devices Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Neurovascular Interventional Devices Sales by Country
  2. 9.1.1 Asia-Pacific Neurovascular Interventional Devices Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Neurovascular Interventional Devices Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Neurovascular Interventional Devices Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Neurovascular Interventional Devices Market Size by Country
  6. 9.2.1 Asia-Pacific Neurovascular Interventional Devices Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Neurovascular Interventional Devices Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Neurovascular Interventional Devices Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Neurovascular Interventional Devices Sales by Country
  2. 10.1.1 South America Neurovascular Interventional Devices Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Neurovascular Interventional Devices Sales by Country (2021-2026)
  4. 10.1.3 South America Neurovascular Interventional Devices Sales Forecast by Country (2027-2032)
  5. 10.2 South America Neurovascular Interventional Devices Market Size by Country
  6. 10.2.1 South America Neurovascular Interventional Devices Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Neurovascular Interventional Devices Market Size by Country (2021-2026)
  8. 10.2.3 South America Neurovascular Interventional Devices Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Neurovascular Interventional Devices Sales by Country
  2. 11.1.1 Middle East and Africa Neurovascular Interventional Devices Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Neurovascular Interventional Devices Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Neurovascular Interventional Devices Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Neurovascular Interventional Devices Market Size by Country
  6. 11.2.1 Middle East and Africa Neurovascular Interventional Devices Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Neurovascular Interventional Devices Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Neurovascular Interventional Devices Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Neurovascular Interventional Devices Value Chain Analysis
  2. 12.1.1 Neurovascular Interventional Devices Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Neurovascular Interventional Devices Production Mode & Process
  7. 12.2 Neurovascular Interventional Devices Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Neurovascular Interventional Devices Distributors
  10. 12.2.3 Neurovascular Interventional Devices Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst